Traumatic brain injury (TBI) is associated with an increased risk of depressive symptoms. Recent imaging studies on spontaneous depression have implicated several brain structures; however, few studies have done the same for post-TBI depression. We report on a pilot observational study correlating atrophy of brain regions of interest in subjects after TBI with depressive symptoms measured by the Beck Depression Inventory-II. Regional brain volumes were calculated on both acute and 6-month MRI using an automated segmentation algorithm (FreeSurfer). Percent volume changes in brain regions were correlated with BDI-II scores using Spearman's rank order correlation coefficient. Correction for multiple comparisons was performed using the false discovery rate (FDR). Three regions of interest (left rostral anterior cingulate and bilateral orbitofrontal cortex) were found to be significantly correlated with depressive symptoms (FDR 0.05). With FDR 0.1, six regions were significantly correlated. The use of volumetric analysis of brain regions of interest to study post-TBI depression is worthy of further study. Regions associated with depressive symptoms in this pilot study were similar to those implicated in study of spontaneous depression.
Introduction
Approximately 1.5 million U.S. civilians per year sustain a traumatic brain injury (TBI) (Langlois et al., 2006) . Rates of major depressive disorder determined by diagnostic interview within the first 12 months are reported to be between 20 and 30% for most studies (Jorge et al., 1993; Fann et al., 1995; van Reekum et al., 1996; Gomez-Hernandez et al., 1997; Rapoport et al., 2006; Ashman et al., 2009 ) and, more recently, up to 53.1% (Bombardier et al., 2010) . In contrast, the 12-month rate of major depression in the general population is 6.7% (Kessler et al., 2005) . Rates of suicide after TBI are known to be elevated up to three- (Harrison-Felix et al., 2009 ; number of suicides 10, expected 3, standardized mortality ratio 2.95, 95% SMR interval 1.42-5.43) to four-fold (Teasdale and Engberg, 2001 ; contusion or intracranial hemorrhage: number of suicides 99 of 11,766 = 0.84%). The current estimate of suicide rate in the general population is 11 per 100,000 (National Institute of Mental Health, 2009 ). Development of depression after TBI worsens outcomes in the functional and psychosocial arenas (Fann et al., 1995; Satz et al., 1998; Deb et al., 1999; Levin et al., 2001; Rapoport et al., 2003; Underhill et al., 2003; Franulic et al., 2004; Jorge et al., 2004) . While progress has been made in understanding the pathophysiology of spontaneous depression, much less is understood regarding the pathophysiology of depression following TBI.
Spontaneous depression has been linked to atrophy in specific brain regions, including the limbic system, prefrontal cortex, anterior cingulate gyrus (Theberge, 2008; Yucel et al., 2008; Kronenberg et al., 2009; Mak et al., 2009) , and gray matter volume (Drevets et al., 1997) . The limbic-frontal model of depression (Mayberg, 1997; Seminowicz, et al., 2004 ) is supported by atrophy in these regions. Koolschijn et al. (2009) reported a meta-analysis on structural MRI and depression, noting significant correlation of depression with decreased volumes in the anterior cingulate gyrus (P value for Cohen's d: left P = 0.005, right P b 0.001), hippocampus (P value for Cohen's d: left P b 0.001, right P b 0.001), orbitofrontal cortex (P value for Cohen's d: left P = 0.002, right P = 0.004) and prefrontal cortex (P value for d: right P = 0.053, left P = 0.045). With no restrictions on the brain regions included, the Koolschijn et al. meta-analysis included 64 studies with 130 brain regions from 2418 subjects and 1974 controls.
There is a paucity of published information delving into the pathophysiology of post-TBI depression. Previously reported work has shown an association between post-TBI depression and atrophy in the prefrontal cortex (Jorge et al., 2004) , hippocampus (Jorge et al., 2007) , anterior cingulate, and dorsolateral prefrontal cortex, among others (Chen et al., 2008) . Jorge et al. in 2004 reported an association between outcome (GOS-E) and hippocampal volumes. What is not yet clear is if post-TBI depression is definitively linked to the limbicfrontal model of depression.
In both general (Douglas and Porter, 2009 ) and TBI populations, depressive symptoms have been reported to impair cognitive function. In the TBI population, depression has been reported to impair working memory (Rapoport et al., 2005) , processing speed (Rapoport et al., 2005) , executive function (Jorge et al., 2004; Rapoport et al., 2005) , and verbal memory (Rapoport et al., 2005) .
In this study we report data from a pilot study examining the relation between volumetric changes after TBI for various brain regions and scores on the Beck Depression Inventory-II (BDI-II) (Beck, et al., 1996) . This is a convenience sample consisting of subjects enrolled in a prospective neuroimaging study (Warner et al., 2010) . For the regions of interest analysis, we selected brain regions that have shown the strongest link between depression and brain atrophy in the non-TBI population (Drevets et al., 1997; Theberge, 2008; Yucel et al., 2008; Kronenberg et al., 2009; Mak et al., 2009; Koolschijn et al., 2009) and have been linked with post-TBI depression in previous work, including superior frontal and middle frontal regions, hippocampus, and rostral anterior cingulate. We also selected areas functionally related to the above-mentioned structures. We explore the relationships between regional brain atrophy and depressive symptom severity as measured by the BDI-II. Further, we explore the relation between depressive symptoms and the impact on neuropsychological data.
Methods

Subjects
We undertook a pilot study on a convenience sample of TBI subjects previously recruited for an imaging study (Warner et al., 2010) . Subjects were recruited between September 2005 and October 2008. Inclusion criteria were as follows: age between 16 and 65 years, required admission to hospital for TBI. Consent was obtained from either the patient or a legally authorized representative. Subjects were excluded if they were found to have 1) pre-existing neurological or psychiatric disorders, conditions that may have resulted in abnormal MRI findings and/or compromised cognitive functions, including prior history of TBI, in an attempt to eliminate any other cause other than the current TBI for alterations in imaging, consciousness or cognition. This information was gathered by experienced research assistants, who utilized the patient, family and medical chart as sources of information. By history, these subjects had no history of suicide attempts, psychiatric hospitalization and were not under the active care of a psychiatrist; 2) presence of focal lesions (including contusions, extra-axial hematoma, and/or intraparenchymal hemorrhages) with volume greater than 10 ml on cranial CT which could provide an alternative explanation for the decline in cognition or consciousness; 3) contraindications to MRI; and 4) prisoners, homeless patients, and pregnant women. Prisoners and homeless patients were excluded because of the difficulties in contacting and arranging the follow-up scan after hospital discharge; pregnant women were excluded due to the potential risk to the fetus. Fiftyeight subjects were enrolled; 14 additional patients were enrolled but were never scanned for a variety of reasons, including death, inability to lie still in the scanner, or MRI incompatible brace or incompatible implanted medical device. Of the 58 subjects recruited, we excluded subjects with only one scan and selected only those subjects with both an acute and chronic scans and who had a scored BDI-II at the time of follow-up MRI. The final sample size consisted of 25 subjects with paired imaging and follow-up data. For a particular subject, the same scanner was used for both the acute and chronic scans. Data on the neuropsychological testing were compared with population normative data available for the tests administered. This study was approved by the institutional review board at the University of Texas Southwestern Medical Center. Analyses for this report were performed using de-identified data.
Imaging methods
Acute and 6-month MRI scans were performed on a GE Signa Excite 3T scanner (15 subjects) (General Electric Healthcare, Milwaukee, Wisconsin) or Siemens 3T (10 subjects) (Siemens Medical Solutions, Erlangen, Germany). For the GE scanner, three-dimensional (3D) T1-weighted structural images were obtained using fast spoiled gradient-recalled acquisition in the steady state (GRASS) sequences with a 256×192 matrix size, 240 mm field of view, 130 slices, 1.3/0 slice thickness/gap ratio, 2.4 ms echo time, 25°flip angle, 2 excitations, and a 6 min acquisition time. For the Siemens scanner, 3D T1-weighted structural MPRAGE images were obtained with a 240 mm field of view, 1.0/0 slice thickness/ gap ratio, 4.0 ms echo time, 900 ms inversion time, 2250 ms repetition time, and 5 min 36 s acquisition time. No major scanner upgrades were performed during the study period and protocols remained consistent. All images were analyzed using FreeSurfer (v4.5.0) software (Arhinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, 2009) on a Macintosh workstation to derive regional subcortical and cortical brain volumes. FreeSurfer has been described in detail in previous publications Fischl and Dale, 2000; Fischl et al., 1999 Fischl et al., , 2002 . To address the potential variability due to the use of two different scanners, five control subjects were scanned on both scanners. Volume measurements for these control subjects had a net intraclass correlation coefficient of 0.996, and there were no significant differences between scanners after correction for multiple comparisons.
Outcome measures
The Beck Depression Inventory-II (BDI-II) (Beck et al., 1996 ) is a 21-question self-report tool measuring symptoms of depression with an ordinal scale. Previously used in the TBI population (Glenn, et al., 2001; Seel and Kreutzer, 2003; Rowland et al., 2005; Chen, et al., 2008) , the BDI-II can be administered through self-report or by oral presentation (Beck, et al., 1996) . It has test-retest reliability of 0.93 (Beck, et al., 1996) .
The Glasgow Outcome Scale-Extended (GOS-E) ) is a 1-8 categorical scale measuring outcome after TBI. It has a test-retest reliability of 0.78 . Administered via a structured interview, it is widely used in the TBI literature .
The Functional Status Examination (FSE) (Dikmen et al., 2001 ) is a 10-domain functional outcome measure designed to describe outcomes in the TBI population. The information provided is more descriptive of functional abilities than the standard GOS-E. It has a test-retest reliability of 0.8 (Dikmen et al., 2001; Kirkness et al., 2002) .
Neuropsychological testing was administered by a trained neuropsychologist. To investigate associations between depression, cerebral atrophy and cognitive outcome, we used a standard neuropsychological battery assessing learning and memory, processing speed, and executive functions. The neurocognitive outcome battery included the WAIS-III (Wechsler, 1997) digit symbol coding, symbol search and digit span backwards from the digit span subtest, Trail Making Tests A and B (Reitan, 1992) , controlled oral word association test (COWAT) (Benton and Hamsher, 1983), Dodrill Stroop (Dodrill, 1978) , and California Verbal Learning Test-II (CVLT-II) (Delis et al., 2000) (total learning, short delay and long delay recalls). This targeted battery was subjected to a factor analysis with varimax rotation to reduce the data to the three domains the battery purports to assess. The resulting three-factor structure accounts for 77% of the variance, and comprises learning and memory (CVLT total learning, CVLT short delay, CVLT long delay (51% of variance)), executive function (COWAT, Digit span, Stroop word reading Stroop color naming (10% of variance)), and processing speed (Trails A and B, digit symbol coding, symbol search (16% of variance)).
Participants' performance on these cognitive tasks was corrected for demographic variables (where available). The result is a standardized score (either a scaled score or a T score), which was subsequently converted to a common Z score scale (i.e., mean = 0, standard deviation = 1) to reflect the degree of deviation from the normal populations from which the normative data are derived. The composite measures for each cognitive domain (i.e., processing speed, learning and memory, and executive functions) were created by summing the Z scores of each of the tests that comprise each domain (see above). These three composite scores were used for subsequent correlation analyses.
Statistical analysis
Medians and inter-quartile range (IQR) are reported for nonnormally distributed measures. Nonparametric analyses were performed because assumptions for parametric analyses were violated. Percent volume changes were calculated by finding the difference between acute and chronic volumes, then dividing by acute volume, and converting to a percent. Selected regions of interest (ROI) (bilateral: rostral and caudal anterior cingulate, medial and lateral orbitofrontal, caudal and rostral middle frontal, superior frontal, and hippocampus) were segmented using FreeSurfer. See Fig. 1 . Percent volume changes of the ROI were correlated with the BDI-II, injury variables and outcome measures using Spearman's rank order correlation coefficients. Multiple comparison corrections at a false discovery rate (FDR) of 0.1 and 0.05 were utilized. All image analyses and volume measurements were performed by a researcher who was blind to a subject's BDI-II score.
In an exploratory hypothesis-generating manner, we calculated the Spearman's rank order coefficients for all measures of cortical volume segmented by FreeSurfer (bilateral: accumbens area, amygdala, caudal anterior cingulate, caudal middle frontal, caudate, cerebellum, cerebellum cortex, cerebral cortex, cerebral white matter, cuneus, entorhinal, frontal pole, fusiform, hippocampus, inferior parietal, inferior temporal insula, isthmus cingulate, lateral occipital, lateral orbitofrontal, lingual, medial orbitofrontal, middle temporal, pallidum, paracentral, parahippocampus, pars opercularis, pars orbitalis, pars triangularis, pericalcarine, posterior central, posterior cingulate, precentral, precuneus, putamen, rostral anterior cingulate, rostral middle frontal, superior frontal, superior parietal, superior temporal, supramarginal, temporal pole, thalamus proper, transverse temporal pole, ventral diencephalon, ventricles; single measures: 3rd ventricle, 4th ventricle, brainstem, corpus callosum-anterior, middle anterior, central, middle posterior, posterior, CSF). We also examined the use of acute volume, chronic volume and absolute change in volume (acute-chronic) for association with BDI-II. The statistical software used for analysis was SAS version 9.2 (SAS for Windows, 2008).
Results
Demographic and clinical characteristics
The median age at injury for this population was 23 years , the majority of whom were right-handed Caucasian males (righthanded 92%; 88% males; 72% Caucasian). Initial median Glasgow Coma Scale (GCS) was 8 (IQR 3-14), indicating half of the subjects had severe TBI; half of the subjects were intubated at the time of scan. Initial scans were done at the median time of 3 days (IQR 1-8) from time of injury. The majority of injuries occurred by motor vehicle collision (64%). Follow-up scans were performed at a median time of 8 months (IQR 7-9), at which time the neuropsychological testing was performed. Twenty percent of subjects had clinically significant depressive symptoms, defined as BDI-II greater than 13 (Beck et al., 1996) . Median GOS-E was 7 (IQR 6-8) and median FSE was 13 (IQR 12-18). Please see Table 1 .
Regions of interest
Correlation analysis with Spearman's rank order coefficient showed significant relationships between BDI-II scores and percent volume change in the ROIs listed in Table 2 . Variables in the analysis included the neuropsychological domains, injury-related measures and subject baseline measures. Information presented in Table 2 represents those regions which significantly correlated with the BDI-II scores after FDR correction of 0.1. Ten regions were not significantly correlated with the BDI-II scores (right rostral anterior cingulate, right and left caudal anterior cingulate, right and left medial orbitofrontal, left caudal middle frontal, right and left rostral middle frontal, right hippocampus, and left superior frontal). After FDR was restricted to 0.05, three regions remained significant (left rostral anterior cingulate, left and right lateral orbitofrontal). GCS was correlated with BDI-II (rho = − 0.52532, P = 0.0070) and survived the FDR correction at both levels (0.1 and 0.05). GOS-E and FSE were moderately correlated with BDI-II (rho = −0.36820, P =0.0701; rho = 0.44646, P = 0.0253, respectively); however, only the FSE was significantly correlated with the BDI-II score after FDR correction at 0.1.
Percent volume change for the hippocampus was not significantly correlated with age (right rho = − 0.06529, P = 0.7565; left rho = 0.18273, P = 0.3820). No significant correlation was found between the functional outcome measures (FSE or GOS-E) and percent hippocampal volume change for the right (GOS-E rho= 0.06254, P = 0.7665, FSE rho = −0.05089, P = 0.8091) or the left (GOS-E rho = −0.29517, P = 0.1520, FSE rho = 0.11343, P = 0.5893).
Z scores of neuropsychological domains were not significantly correlated with BDI-II scores after correction for multiple testing using FDR set at either 0.1 or 0.05. The learning and memory domain, however, did reveal a trend towards significance. See Table 3 .
All brain regions supplied by FreeSurfer
In an exploratory manner, we performed Spearman's rank order correlation analyses for all available brain region volumes and BDI-II, using FDR corrections at 0.1 and 0.05. Also included were subject baseline characteristics, injury-related measures, outcome measures and neuropsychological domains. The variables listed in Table 4 were significant at 0.1 FDR. No regions survived 0.05 FDR.
Spearman's rank order correlation coefficients were calculated for all brain region absolute volumes, grouping by time of imaging (acute and chronic). No region was significantly correlated to BDI-II scores when we applied FDR of 0.1. When we examined the absolute change in volumes, eight structures were significantly correlated to BDI-II with FDR of 0.1; see Table 5 . No absolute change in volume was significantly correlated with BDI-II scores when FDR was restricted to 0.05. Interestingly, with the FDR at 0.1, there were two regions, left rostral anterior cingulate and left lateral orbitofrontal cortex, that remained significant across the different analyses (absolute volume change, percent volume change, region of interest analysis and all available regions).
Discussion
The portion of this sample that endorsed clinically significant depressive symptoms (20%), defined as BDI-II score greater than 13, is consistent with previously published reports (Jorge et al., 1993; Fann et al., 1995; van Reekum et al., 1996; Gomez-Hernandez et al., 1997; Rapoport et al., 2006; Ashman et al., 2009) . Of the 16 candidate regions selected from the general depression literature and previous studies of post-TBI depression, six were significantly correlated with BDI-II scores at 0.1 FDR. This number decreased to three when FDR was restricted to 0.05. While the orbitofrontal gyrus has previously been associated with depressive symptoms in the general population, this information has not previously been reported for the TBI population. The superior frontal and middle frontal regions have been associated with TBI-related depression. However, this previous finding was in the left hemisphere (Jorge et al., 2004) , whereas ours was on the contralateral side. The hippocampus association with post-TBI depression has been reported by Jorge et al. (2007) . The rostral anterior cingulate association was reported by Chen et al. (2008) in a sample of male mild TBI subjects. Injury severity as measured by the GCS was significant at both levels of FDR. Of the outcome measures, only the FSE was shown to be significantly associated with depressive symptoms (FDR = 0.1).
There is little prior work on the pathophysiology of post-TBI depression. TBI results in heterogeneous lesions, with focal or more diffuse damage or a combination of both, or damage related to secondary injury. The current literature on post-TBI depression indicates that not all TBI survivors develop depression and a history of depression does not mean that depression will occur after TBI (Federoff et al., 1992; Fann et al., 1995; Deb et al., 1999; Jorge and Robinson, 2002; Rapoport et al., 2005; Rapoport et al., 2006) . Many clinicians believe that post-TBI depression is more resistant to treatment than spontaneous depression, but that has not been empirically investigated. Depression can occur at any time after injury with studies documenting an increased incidence up to 30 to 50 years after injury (Holsinger et al., 2002; Koponen et al., 2002; Koponen et al., 2006) . Regional brain atrophy related to spontaneous depression has a long record of investigation, as evidenced by the numerous Chen et al. (2008) reported on mild TBI in an all male sample and found an association of depressive symptoms with atrophy of the rostral anterior cingulate, bilateral dorsolateral prefrontal cortex, bilateral insula, and left parahippocampus. Our study used novel automated techniques that allowed us to measure and compare more than 100 regions in an unbiased manner. The associations reported in this article indicate an overlap of regions involved with post-TBI depression and spontaneous depression. This information supports an anatomical pathophysiology similar to spontaneous depression, with atrophy occurring in these same regions, and is consistent with the limbic-frontal model of depression (Mayberg, 1997; Seminowicz, et al., 2004) .
In this limited data set, injury severity (GCS) correlated with the severity of depression. The correlation of functional measures (FSE and GOS-E) with depressive symptoms was significant only for the FSE and only when the FDR was set at 0.1. The failure of the GOS-E to correlate with neuroimaging measures is likely due to this instrument's insensitivity to functional decrements associated with depression. The FSE, on the other hand, is sensitive to more subtle decrements in general functional abilities including mood, as it measures the degree of impairment in 10 functional domains as opposed to the presence or absence of impairment in a domain.
The Z scores from the neuropsychological domains were not significantly associated with depressive symptoms. The domain with the smallest P value was learning and memory. If the sample size had been larger, the association between this domain and BDI-II may have indeed reached significance. Further, had the sample size been larger, it may have been possible to analyze these tests individually rather than using factor scores derived from a data reduction technique.
Limitations
These data were collected for purposes other than this study. Information concerning current or previous treatment for depression, history of depression, or family history of depression was not collected, but is necessary to gain a more complete understanding of vulnerabilities and treatment options. This sample did not undergo a structured diagnostic interview; therefore, DSM-IV-TR criteria cannot be applied. This element is critical for understanding post-TBI depression and achieving an accurate diagnosis, and it would allow for more structured and rigorous analyses in future studies. It does not, however, lend itself to early evaluation of comatose subjects or subjects in post-traumatic amnesia as a means of screening for certain psychiatric disorders. While we attempted to exclude subjects with pre-morbid psychiatric disease, some subjects with undiagnosed psychiatric conditions could have been inadvertently included. The small sample size in this investigation is a reflection of the study's pilot status. It is likely that other brain regions and variables may have survived FDR correction if the sample size was larger. We cannot be certain without a doubt that the reported atrophy is due to the TBI, secondary injury or other mechanism. This pilot provides a starting point for future much needed work. While the use of two different scanners may be considered a limitation, we found the betweenscanner variation to have an intraclass correlation coefficient of 0.996, suggesting that the scans are quite similar despite being acquired on two different scanners. This also represents the reality of clinical care, where a patient may be scanned on more than one MRI scanner. The possibility of impaired self-awareness (ISA) in the TBI population demands mention. A known potential result of TBI, this process could hinder the ability of subjects to self-report depressive symptoms. In fact, Malec et al. (2007) found an association with the perception of impairment and depression. There was no measure of this potential confounder. Some of the impact should have been mitigated by the time from injury to when the BDI-II was collected (median 8 months). Should a prospective study be attempted in the future, the use of one scanner would be advised. The authors would also recommend that future work be done on samples with the same level of injury and be age-and gender-matched with controls. Additionally, the use of a diagnostic psychiatric interview, when the subjects are able to participate, is recommended.
Conclusion
There is limited information in the literature regarding the pathophysiology of post-TBI depression. The pilot data presented here support the need for further investigation and verify that structural imaging is a potentially useful method for investigating post-TBI depression. Future work requires the utilization of a diagnostic interview, a larger sample size, measures of ISA, and a mix of TBI lesions with sufficient numbers to permit stratification by injury type. Our results suggest that the pathophysiology of post-TBI depression overlaps with spontaneous depression. Understanding the pathophysiology of post-TBI depression is the key to treatment and perhaps prevention of this common disabling condition. 
